Advertisement

Journal of Urban Health

, Volume 96, Issue 3, pp 379–389 | Cite as

Sources of Stress among Adults with Co-occurring Drug Use and Depressive Symptoms

  • Kayla N. TormohlenEmail author
  • Karin E. Tobin
  • Carl Latkin
Article
  • 109 Downloads

Abstract

Stress, drug use, and depression are interconnected, but less is understood about sources of stress among adults with co-occurring drug use and depressive symptoms. The current study aimed to identify sources of stress and correlates among these adults. Data come from a cross-sectional baseline survey, including participants (n = 336) 18 to 55 years old, who reported past 6-month heroin or cocaine use and depressive symptoms. Exploratory factor analysis was conducted to identify sources of stress. Chi-square and multivariable Poisson regression with robust error variance were used to explore correlates of each factor. Three sources of stress were identified: financial stress related to drugs, stress due to community features, and stress involving a person’s network. Past 6-month injection drug use (aPR = 1.34, 95% CI 1.07–1.67), perceived lack of control over drug use (aPR = 1.80, 95% CI 1.41–2.30), and difficulty abstaining from drug use (aPR = 1.55, 95% CI 1.22–1.97) were associated with an increased risk of high drug-related financial stress. Neighborhood disorder (aPR = 2.42, 95% CI 1.80–3.24) and sleeping on the street (aPR = 1.37, 95% CI 1.04–1.80) were associated with an increased risk of high community-level stress. Past 6-month injection drug use (aPR = 1.28, 95% CI 1.04–1.58), perceived lack of control over drug use (aPR = 1.37, 95% CI 1.10–1.70), and drug use stigma was associated with an increased prevalence of high drug network stress (aPR = 1.32, 95% CI 1.05–1.65). Stress is a complex construct, including distinct sources and correlates. Further understanding of sources of stress is beneficial in recognizing potentially modifiable challenges faced by individuals who use drugs and experience depressive symptoms.

Keywords

Stress Drug use Depression Co-occurring disorders 

Notes

Acknowledgments

This work was supported by two National Institutes of Health (NIH) grants [R01DA022961, Latkin PI; T32DA007292, Tormohlen].

Compliance with Ethical Standards

The study was approved by the Johns Hopkins Bloomberg School of Public Health Institutional Review Board.

Disclaimer

The work is solely the responsibility of the authors and does not necessarily reflect the official views of the NIH. The funding source did not play a role in determining study design, data collection, analysis or interpretation, writing the report, or the decision to submit the report for publication.

References

  1. 1.
    Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2016 National Survey on Drug Use and Health (HHS Publication No. SMA 17-5044, NSDUH Series H-52). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2017. https://www.samhsa.gov/data/. Accessed 3 Apr 2018.
  2. 2.
    Park-Lee E, Lipari RN, Hedden SL, Kroutil L, Porter JD. Receipt of services for substance use and mental health issues among adults: results from the 2016 National Survey on Drug Use and Health: NSDUH Data Review; 2017. http://www.samhsa.gov/data/. Accessed April 3, 2018.
  3. 3.
    Kendler KS, Prescott CA, Myers J, Neale MC. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch Gen Psychiatry. 2003;60(9):929–37.CrossRefGoogle Scholar
  4. 4.
    Conner KR, Pinquart M, Duberstein PR. Meta-analysis of depression and substance use and impairment among intravenous drug users (IDUs). Addiction. 2008;103(4):524–34.CrossRefGoogle Scholar
  5. 5.
    Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry. 1985;142(11):65–74.Google Scholar
  6. 6.
    Brady KT, Sinha R. Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress. Am J Psychiatr. 2005;162(8):1483–93.CrossRefGoogle Scholar
  7. 7.
    Davis L, Uezato A, Newell JM, Frazier E. Major depression and comorbid substance use disorders. Curr Opin Psychiatry. 2008;21(1):14–8.CrossRefGoogle Scholar
  8. 8.
    McNiel DE, Binder RL, Robinson JC. Incarceration associated with homelessness, mental disorder, and co-occurring substance abuse. Psychiatr Serv. 2005;56(7):840–6.CrossRefGoogle Scholar
  9. 9.
    Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51(1):8–19.CrossRefGoogle Scholar
  10. 10.
    Sinha R. Chronic stress, drug use, and vulnerability to addiction. Ann N Y Acad Sci. 2008;1141(1):105–30.CrossRefGoogle Scholar
  11. 11.
    Sinha R. How does stress increase risk of drug abuse and relapse? Psychopharmacology. 2001;158(4):343–359.Google Scholar
  12. 12.
    Laudet AB, Magura S, Vogel HS, Knight EL. Perceived reasons for substance misuse among persons with a psychiatric disorder. Am J Orthop. 2004;74(3):365.CrossRefGoogle Scholar
  13. 13.
    Ahern J, Stuber J, Galea S. Stigma, discrimination and the health of illicit drug users. Drug Alcohol Depend. 2007;88(2):188–96.CrossRefGoogle Scholar
  14. 14.
    Hill TD, Angel RJ. Neighborhood disorder, psychological distress, and heavy drinking. Soc Sci Med. 2005;61(5):965–75.CrossRefGoogle Scholar
  15. 15.
    Fox HC, Talih M, Malison R, Anderson GM, Kreek MJ, Sinha R. Frequency of recent cocaine and alcohol use affects drug craving and associated responses to stress and drug-related cues. Psychoneuroendocrinology. 2005;30(9):880–91.CrossRefGoogle Scholar
  16. 16.
    Ouimette PC, Brown PJ, Najavits LM. Course and treatment of patients with both substance use and posttraumatic stress disorders. Addict Behav. 1998;23(6):785–95.CrossRefGoogle Scholar
  17. 17.
    Hartgers C, Hoek J, Coutinho R, Pligt J. Psychopathology, stress and HIV-risk injecting behaviour among drug users. Addiction. 1992;87(6):857–65.CrossRefGoogle Scholar
  18. 18.
    Lazarus RS. Stress and Emotion: A New Synthesis. New York, NY: Springer Publishing Co; 1999.Google Scholar
  19. 19.
    Cohen S, Kessler RC, Underwood Gordon L. Strategies for measuring stress in studies of psychiatric and physical disorders. In: Cohen S, Kessler RC, Underwood Gordon L, editors. Measuring Stress: A Guide for Health and Social Scientists. New York, NY: Oxford University Press, Inc; 1997.Google Scholar
  20. 20.
    Levine S, et al. Psychoneuroendocrinology. 2005;30(10):939–46.CrossRefGoogle Scholar
  21. 21.
    Marlatt GA, Donovan DM. Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors. New York, NY: The Guilford Press; 2005.Google Scholar
  22. 22.
    Hammen C. Stress and depression. Annu Rev Clin Psychol. 2005;1:293–319.CrossRefGoogle Scholar
  23. 23.
    Mazure CM. Life stressors as risk factors in depression. Clin Psychol Sci Pract. 1998;5(3):291–313.CrossRefGoogle Scholar
  24. 24.
    Latkin C, Curry D. Stressful neighborhoods and depression: a prospective study of the impact of neighborhood disorder. J Health Soc Behav. 2003;44(1):34–44.CrossRefGoogle Scholar
  25. 25.
    Cohen S, Janicki-Deverts D, Miller GE. Psychological stress and disease. JAMA. 2007;298(14):1685–7.CrossRefGoogle Scholar
  26. 26.
    Boardman JD, Finch BK, Ellison CG, Williams DR, Jackson JS. Neighborhood disadvantage, stress, and drug use among adults. J Health Soc Behav. 2001;42(2):151–65.CrossRefGoogle Scholar
  27. 27.
    Young M, Stuber J, Ahern J, Galea S. Interpersonal discrimination and the health of illicit drug users. Am J Drug Alcohol Abuse. 2005;31(3):371–91.CrossRefGoogle Scholar
  28. 28.
    Latkin C, Davey-Rothwell M, Yang J-Y, Crawford N. The relationship between drug user stigma and depression among inner-city drug users in Baltimore, MD. J Urban Health. 2013;90(1):147–56.CrossRefGoogle Scholar
  29. 29.
    Tobin K, Davey-Rothwell M, Nonyane B, Knowlton A, Lawrence W, Latkin C. RCT of an integrated CBT-HIV intervention on depressive symptoms and HIV risk. PLoS One. 2017;12(12):1–12.CrossRefGoogle Scholar
  30. 30.
    Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Mes. 1977;1(3):385–401.CrossRefGoogle Scholar
  31. 31.
    Radloff LS, Locke BZ. The community mental health assessment survey and the CES-D scale. In: Weissman MM, Myers JK, Ross CE, editors. Community Surveys of Psychiatric Disorders. New Brunswick, NJ: Rutgers University Press; 1986: 177–189.Google Scholar
  32. 32.
    Boyd JH, Weissman MM, Thompson WD, Myers JK. Screening for depression in a community sample: understanding the discrepancies between depression symptom and diagnostic scales. Arch Gen Psychiatry. 1982;39(10):1195–200.CrossRefGoogle Scholar
  33. 33.
    Bland JM, Altman DG. Statistics notes: Cronbach’s alpha. BMJ. 1997;314(7080):572.CrossRefGoogle Scholar
  34. 34.
    DeVellis RF. Scale Development: Theory and Applications. Thousand Oaks, CA: Sage Publications; 2016.Google Scholar
  35. 35.
    Perkins DD, Meeks JW, Taylor RB. The physical environment of street blocks and resident perceptions of crime and disorder: implications for theory and measurement. J Enviorn Psychol. 1992;12(1):21–34.CrossRefGoogle Scholar
  36. 36.
    Kim J-O, Mueller CW. Factor Analysis: Statistical Methods and Practical Issues. Uslaner EM, editor. Volume 14. Beverly Hills, CA: Sage Publications; 1978.Google Scholar
  37. 37.
    Kaiser HF. The application of electronic computers to factor analysis. Educ Psychol Meas. 1960;20(1):141–51.CrossRefGoogle Scholar
  38. 38.
    Holgado-Tello FP, Chacón-Moscoso S, Barbero-García I, Vila-Abad E. Polychoric versus Pearson correlations in exploratory and confirmatory factor analysis of ordinal variables. Qual Quant. 2010;44(1):153–66.CrossRefGoogle Scholar
  39. 39.
    Costello AB, Osborne JW. Best practices in exploratory factor analysis: four recommendations for getting the most from your analysis. Practical Assessment, Research & Evaluation. 2005;10(7):1–9.Google Scholar
  40. 40.
    Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702–6.CrossRefGoogle Scholar
  41. 41.
    Latkin C, Mandell W, Vlahov D, Oziemkowska M, Celentano D. People and places: behavioral settings and personal network characteristics as correlates of needle sharing. J Acquir Immune Defic Syndr. 1996;13(3):273–80.CrossRefGoogle Scholar
  42. 42.
    Rhodes T, Singer M, Bourgois P, Friedman SR, Strathdee SA. The social structural production of HIV risk among injecting drug users. Soc Sci Med. 2005;61(5):1026–44.CrossRefGoogle Scholar
  43. 43.
    Latkin CA, Forman V, Knowlton A, Sherman S. Norms, social networks, and HIV-related risk behaviors among urban disadvantaged drug users. Soc Sci Med. 2003;56(3):465–76.CrossRefGoogle Scholar
  44. 44.
    Link BG, Phelan JC. Conceptualizing stigma. Ann Rev Sociol. 2001;27(1):363–85.CrossRefGoogle Scholar

Copyright information

© The New York Academy of Medicine 2018

Authors and Affiliations

  1. 1.Department of Mental HealthJohns Hopkins Bloomberg School of Public HealthBaltimoreUSA
  2. 2.Department of Health, Behavior and SocietyJohns Hopkins Bloomberg School of Public HealthBaltimoreUSA
  3. 3.Department of Health, Behavior and SocietyJohns Hopkins Bloomberg School of Public HealthBaltimoreUSA

Personalised recommendations